Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 5 Key Players companies in Enzalutamide
by Highest Patent Value in the United States in 2022

The Enzalutamide top 5 is Discovery PatSnap’ annual ranking of the top 5 Highest Patent Value Enzalutamide Key Players in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Enzalutamide is used to treat men with a certain type of prostate cancer.
#
Company Name
Region
Tech Topics
Total
1
Medivation Prostate Therapeutics LLC
Drug,Medicine
Avg patent value: 5.98 M
2
Boehringer Ingelheim Pharmaceuticals, Inc.
Central nervous system,Medicine,Drug,
...[+2]
Avg patent value: 1.76 M
3
PSMA Development Co. LLC
Cancer immunotherapy,Cancer,Medicine
Avg patent value: 660,000
4
Aragon Pharmaceuticals, Inc.
Medicine,Health care,Pharmacy and Therapeutics,
...[+2]
Avg patent value: 252,410
5
Aptevo Research & Development LLC
Biotechnology
Avg patent value: 23,000
Page generation time: Jun 26 2025